Press Releases

 
Press Releases
  Date Title View
May 1, 2017
RADNOR, Pa., May 01, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the "Company"), a biopharmaceutical com...
Apr 18, 2017
Platform Presentation of Phase 2 Data in Fragile X Syndrome RADNOR, Pa., April 18, 2017 (GLOBE NEWSWIRE) -- ...
Apr 11, 2017
RADNOR, Pa., April 11, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated...
Apr 10, 2017
RADNOR, Pa., April 10, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated...
Mar 15, 2017
RADNOR, Pa., March 15, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated...
Mar 13, 2017
RADNOR, Pa., March 13, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharm...
Feb 14, 2017
Data Published in NeuropharmacologyRADNOR, Pa., Feb. 14, 2017 (GLOBE NEWSWIRE) -- ...
Feb 1, 2017
RADNOR, Pa., Feb. 01, 2017 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to ...
Jan 23, 2017
Plans to Apply for Orphan Drug Designation RADNOR, Pa., Jan. 23, 2017 (GLOBE NEWSWIRE) -- Marinus Phar...
Jan 5, 2017
Several Data Milestones Anticipated With Ganaxolone RADNOR, Pa., Jan. 05, 2017 (GLOBE NEWSWIRE) -- ...
1
...
NextLast
= add release to Briefcase